Leon B
Trends Immunol. 2025; 46(2):104-120.
PMID: 39843310
PMC: 11835539.
DOI: 10.1016/j.it.2024.12.005.
Shouse A, Villarino A, Malek T
iScience. 2025; 27(12):111248.
PMID: 39759017
PMC: 11700635.
DOI: 10.1016/j.isci.2024.111248.
Jamison B, Lawrance M, Wang C, DeBerg H, Ziegler L, Sansom D
Cell Rep. 2024; 43(11):114938.
PMID: 39488830
PMC: 11602548.
DOI: 10.1016/j.celrep.2024.114938.
Zhang H, Felthaus O, Eigenberger A, Klein S, Prantl L
Cells. 2024; 13(18.
PMID: 39329710
PMC: 11429654.
DOI: 10.3390/cells13181526.
Pahl M, Sharma P, Thomas R, Thompson Z, Mount Z, Pippin J
Elife. 2024; 13.
PMID: 39302339
PMC: 11418197.
DOI: 10.7554/eLife.96852.
Striking a balance: new perspectives on homeostatic dendritic cell maturation.
Bosteels V, Janssens S
Nat Rev Immunol. 2024; 25(2):125-140.
PMID: 39289483
DOI: 10.1038/s41577-024-01079-5.
Effector memory-type regulatory T cells display phenotypic and functional instability.
Wendering D, Amini L, Schlickeiser S, Farrera-Sal M, Schulenberg S, Peter L
Sci Adv. 2024; 10(36):eadn3470.
PMID: 39231218
PMC: 11421655.
DOI: 10.1126/sciadv.adn3470.
Interruption of the intratumor CD8 T cell:Treg crosstalk improves the efficacy of PD-1 immunotherapy.
Geels S, Moshensky A, Sousa R, Murat C, Bustos M, Walker B
Cancer Cell. 2024; 42(6):1051-1066.e7.
PMID: 38861924
PMC: 11285091.
DOI: 10.1016/j.ccell.2024.05.013.
The double life of a chemotherapy drug: Immunomodulatory functions of gemcitabine in cancer.
Larson A, Doty K, Solheim J
Cancer Med. 2024; 13(10):e7287.
PMID: 38770637
PMC: 11106691.
DOI: 10.1002/cam4.7287.
Deciphering the developmental trajectory of tissue-resident Foxp3 regulatory T cells.
Alvarez F, Liu Z, Bay A, Piccirillo C
Front Immunol. 2024; 15:1331846.
PMID: 38605970
PMC: 11007185.
DOI: 10.3389/fimmu.2024.1331846.
Interleukin-2 signaling in the regulation of T cell biology in autoimmunity and cancer.
Shouse A, LaPorte K, Malek T
Immunity. 2024; 57(3):414-428.
PMID: 38479359
PMC: 11126276.
DOI: 10.1016/j.immuni.2024.02.001.
Mediator complex subunit 1 architects a tumorigenic Treg cell program independent of inflammation.
Chaudhuri S, Weinberg S, Wang D, Yalom L, Montauti E, Iyer R
Cell Rep Med. 2024; 5(3):101441.
PMID: 38428427
PMC: 10983042.
DOI: 10.1016/j.xcrm.2024.101441.
Targeting the NF-κB pathway as a potential regulator of immune checkpoints in cancer immunotherapy.
Ebrahimi N, Abdulwahid A, Mansouri A, Karimi N, Bostani R, Beiranvand S
Cell Mol Life Sci. 2024; 81(1):106.
PMID: 38418707
PMC: 10902086.
DOI: 10.1007/s00018-023-05098-8.
PD-1 or CTLA-4 blockade promotes CD86-driven Treg responses upon radiotherapy of lymphocyte-depleted cancer in mice.
Frijlink E, Bosma D, Bosma D, Busselaar J, Battaglia T, Staal M
J Clin Invest. 2024; 134(6).
PMID: 38349740
PMC: 10940086.
DOI: 10.1172/JCI171154.
An IL-2 mutein increases IL-10 and CTLA-4-dependent suppression of dendritic cells by regulatory T cells.
Jamison B, Lawrance M, Wang C, DeBerg H, Sansom D, Gavin M
bioRxiv. 2023; .
PMID: 38106196
PMC: 10723345.
DOI: 10.1101/2023.12.01.569613.
RIPK1 plays a crucial role in maintaining regulatory T-Cell homeostasis by inhibiting both RIPK3- and FADD-mediated cell death.
Deng X, Wang L, Zhai Y, Liu Q, Du F, Zhang Y
Cell Mol Immunol. 2023; 21(1):80-90.
PMID: 38082146
PMC: 10757712.
DOI: 10.1038/s41423-023-01113-x.
Transcriptome profiling of regulatory T cells from children with transient hypogammaglobulinemia of infancy.
Rutkowska-Zapala M, Grabowska A, Lenart M, Kluczewska A, Szaflarska A, Kobylarz K
Clin Exp Immunol. 2023; 214(3):275-288.
PMID: 37936298
PMC: 10719223.
DOI: 10.1093/cei/uxad116.
Construction and validation of a metabolism-associated gene signature for predicting the prognosis, immune landscape, and drug sensitivity in bladder cancer.
Shen C, Bi Y, Chai W, Zhang Z, Yang S, Liu Y
BMC Med Genomics. 2023; 16(1):264.
PMID: 37880682
PMC: 10601123.
DOI: 10.1186/s12920-023-01678-6.
Attenuated IL-2 muteins leverage the TCR signal to enhance regulatory T cell homeostasis and response .
Ma S, So M, Ghelani A, Srivas R, Sahoo A, Hall R
Front Immunol. 2023; 14:1257652.
PMID: 37809101
PMC: 10556740.
DOI: 10.3389/fimmu.2023.1257652.
Diversity of intratumoral regulatory T cells in B-cell non-Hodgkin lymphoma.
Spasevska I, Sharma A, Steen C, Josefsson S, Blaker Y, Kolstad A
Blood Adv. 2023; 7(23):7216-7230.
PMID: 37695745
PMC: 10698546.
DOI: 10.1182/bloodadvances.2023010158.